{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:33:15Z","timestamp":1787045595502,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11102-026-01740-3","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:15:27Z","timestamp":1787044527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiometabolic effects of sequential prolactin states in dopamine agonist-treated prolactinoma patients: a retrospective longitudinal study"],"prefix":"10.1007","volume":"29","author":[{"given":"Pedro","family":"Iglesias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores Moure","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Guerrero-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreu","family":"Sim\u00f3-Servat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Gonz\u00e1lez","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Fern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia P\u00e9rez","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Villar-Taibo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betina","family":"Biagetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Orois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Donato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Alc\u00e1zar","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Roig-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soralla","family":"Civantos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Mar\u00eda Fernandez","family":"de Araoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Pav\u00f3n","family":"de Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Outeiri\u00f1o-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cordido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio Garc\u00eda","family":"Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Araujo-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Paja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia Alexandra","family":"Hanzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"1740_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1015520","volume":"13","author":"R Pirchio","year":"2022","unstructured":"Pirchio R, Graziadio C, Colao A et al (2022) Metabolic effects of prolactin. Front Endocrinol (Lausanne) 13:1015520. https:\/\/doi.org\/10.3389\/fendo.2022.1015520","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1740_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3836","volume":"40","author":"T Wu","year":"2024","unstructured":"Wu T, Duan Y, Jiang J et al (2024) A century of prolactin: emerging perspectives as a metabolic regulator. Diabetes Metab Res Rev 40:e3836. https:\/\/doi.org\/10.1002\/dmrr.3836","journal-title":"Diabetes Metab Res Rev"},{"key":"1740_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1002320","volume":"13","author":"P Kirsch","year":"2022","unstructured":"Kirsch P, Kunadia J, Shah S, Agrawal N (2022) Metabolic effects of prolactin and the role of dopamine agonists: a review. Front Endocrinol (Lausanne) 13:1002320. https:\/\/doi.org\/10.3389\/fendo.2022.1002320","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1740_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1018090","volume":"13","author":"A Glezer","year":"2022","unstructured":"Glezer A, Santana MR, Bronstein MD et al (2022) The interplay between prolactin and cardiovascular disease. Front Endocrinol (Lausanne) 13:1018090. https:\/\/doi.org\/10.3389\/fendo.2022.1018090","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1740_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR et al (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:273\u2013288. https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metab"},{"key":"1740_CR6","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol 19:722\u2013740. https:\/\/doi.org\/10.1038\/s41574-023-00886-5","journal-title":"Nat Rev Endocrinol"},{"key":"1740_CR7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000357810","volume":"98","author":"RS Auriemma","year":"2013","unstructured":"Auriemma RS, Granieri L, Galdiero M et al (2013) Effect of cabergoline on metabolism in prolactinomas. Neuroendocrinology 98:299\u2013310. https:\/\/doi.org\/10.1159\/000357810","journal-title":"Neuroendocrinology"},{"key":"1740_CR8","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/oby.2010.150","volume":"19","author":"CM dos Santos Silva","year":"2011","unstructured":"dos Santos Silva CM, Barbosa FRP, Lima GAB et al (2011) BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists. Obes (Silver Spring) 19:800\u2013805. https:\/\/doi.org\/10.1038\/oby.2010.150","journal-title":"Obes (Silver Spring)"},{"key":"1740_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11102-010-0277-9","volume":"14","author":"K Berinder","year":"2011","unstructured":"Berinder K, Nystr\u00f6m T, H\u00f6ybye C et al (2011) Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy. Pituitary 14:199\u2013207. https:\/\/doi.org\/10.1007\/s11102-010-0277-9","journal-title":"Pituitary"},{"key":"1740_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/cen.12204","volume":"79","author":"A Ciresi","year":"2013","unstructured":"Ciresi A, Amato MC, Guarnotta V et al (2013) Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels. Clin Endocrinol (Oxf) 79:845\u2013852. https:\/\/doi.org\/10.1111\/cen.12204","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1740_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/cen.70095","volume":"104","author":"P Iglesias","year":"2026","unstructured":"Iglesias P, Rodr\u00edguez MDM, Guerrero-P\u00e9rez F et al (2026) Sex- and Age-Specific Metabolic Outcomes of Prolactin Normalisation in Hyperprolactinaemia. Clin Endocrinol (Oxf) 104:483\u2013492. https:\/\/doi.org\/10.1111\/cen.70095","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1740_CR12","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.tem.2020.01.004","volume":"31","author":"Y Macotela","year":"2020","unstructured":"Macotela Y, Triebel J, Clapp C (2020) Time for a New Perspective on Prolactin in Metabolism. Trends Endocrinol Metab 31:276\u2013286. https:\/\/doi.org\/10.1016\/j.tem.2020.01.004","journal-title":"Trends Endocrinol Metab"},{"key":"1740_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/17446651.2022.2144829","volume":"17","author":"G Corona","year":"2022","unstructured":"Corona G, Rastrelli G, Comeglio P et al (2022) The metabolic role of prolactin: systematic review, meta-analysis and preclinical considerations. Expert Rev Endocrinol Metab 17:533\u2013545. https:\/\/doi.org\/10.1080\/17446651.2022.2144829","journal-title":"Expert Rev Endocrinol Metab"},{"key":"1740_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70067","volume":"28","author":"AT Zaidalkilani","year":"2024","unstructured":"Zaidalkilani AT, Al-Kuraishy HM, Al-Gareeb AI et al (2024) The beneficial and detrimental effects of prolactin hormone on metabolic syndrome: a double-edge sword. J Cell Mol Med 28:e70067. https:\/\/doi.org\/10.1111\/jcmm.70067","journal-title":"J Cell Mol Med"},{"key":"1740_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/cen.70068","volume":"104","author":"RM Paragliola","year":"2026","unstructured":"Paragliola RM, Corsello A, Cera G et al (2026) Hypoprolactinemia: Biology, Clinical Relevance, and Diagnostic Challenges. Clin Endocrinol (Oxf) 104:188\u2013199. https:\/\/doi.org\/10.1111\/cen.70068","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1740_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.769744","volume":"12","author":"R Pirchio","year":"2021","unstructured":"Pirchio R, Auriemma RS, Solari D et al (2021) Effects of pituitary surgery and high-dose cabergoline therapy on metabolic profile in patients with prolactinoma resistant to conventional cabergoline treatment. Front Endocrinol (Lausanne) 12:769744. https:\/\/doi.org\/10.3389\/fendo.2021.769744","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1740_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11102-024-01393-0","volume":"27","author":"I Uzun","year":"2024","unstructured":"Uzun I, Karaca Z, Hacio\u011flu A et al (2024) The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions. Pituitary 27:277\u2013286. https:\/\/doi.org\/10.1007\/s11102-024-01393-0","journal-title":"Pituitary"},{"key":"1740_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s12020-022-03238-x","volume":"79","author":"M Kabootari","year":"2023","unstructured":"Kabootari M, Shirmohammadli H, Golgiri F et al (2023) Metabolic effects of dopamine-agonists treatment among patients with prolactinomas. Endocrine 79:537\u2013544. https:\/\/doi.org\/10.1007\/s12020-022-03238-x","journal-title":"Endocrine"},{"key":"1740_CR19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17824","volume":"13","author":"G Khalil","year":"2021","unstructured":"Khalil G, Khan FA, Jamal QM et al (2021) Change in insulin sensitivity and lipid profile after dopamine agonist therapy in patients with prolactinoma. Cureus 13:e17824. https:\/\/doi.org\/10.7759\/cureus.17824","journal-title":"Cureus"},{"key":"1740_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-026-04554-2","volume":"91","author":"P Iglesias","year":"2026","unstructured":"Iglesias P, Rodr\u00edguez MDM, Guerrero-P\u00e9rez F et al (2026) Sex differences in cardiovascular risk factors and cardiovascular disease in patients with hyperprolactinemia: a multicenter cross-sectional study. Endocrine 91:65. https:\/\/doi.org\/10.1007\/s12020-026-04554-2","journal-title":"Endocrine"},{"key":"1740_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.rec.2016.02.009","volume":"69","author":"J Aranceta-Bartrina","year":"2016","unstructured":"Aranceta-Bartrina J, P\u00e9rez-Rodrigo C, Alberdi-Aresti G et al (2016) Prevalence of General Obesity and Abdominal Obesity in the Spanish Adult Population (Aged 25\u201364 Years) 2014\u20132015: The ENPE Study. Rev Esp Cardiol (Engl Ed) 69:579\u2013587. https:\/\/doi.org\/10.1016\/j.rec.2016.02.009","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"1740_CR22","doi-asserted-by":"publisher","first-page":"501643","DOI":"10.1016\/j.endien.2025.501643","volume":"72","author":"I Breton","year":"2025","unstructured":"Breton I, Aranbarri I, Lampropoulou A et al (2025) The overweight and obesity landscape in Spain: Data from the Spanish cohort of the multi-country IMPACT-O study. Endocrinol Diabetes Nutr (Engl Ed) 72:501643. https:\/\/doi.org\/10.1016\/j.endien.2025.501643","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"1740_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12020-019-02170-x","volume":"67","author":"AJ Ponce","year":"2020","unstructured":"Ponce AJ, Galv\u00e1n-Salas T, Lerma-Alvarado RM et al (2020) Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans. Endocrine 67:331\u2013343. https:\/\/doi.org\/10.1007\/s12020-019-02170-x","journal-title":"Endocrine"},{"key":"1740_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1159\/000527333","volume":"147","author":"R Krysiak","year":"2022","unstructured":"Krysiak R, Kowalcze K, Okopie\u0144 B (2022) Cabergoline-Induced Hypoprolactinemia May Attenuate Cardiometabolic Effects of Atorvastatin: A Pilot Study. Cardiology 147:497\u2013506. https:\/\/doi.org\/10.1159\/000527333","journal-title":"Cardiology"},{"key":"1740_CR25","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/ejendo\/lvaf101","volume":"192","author":"TS Han","year":"2025","unstructured":"Han TS, Hannemann A, Arffman R et al (2025) The relationship between hypoprolactinemia and cardiometabolic health in women. Eur J Endocrinol 192:662\u2013670. https:\/\/doi.org\/10.1093\/ejendo\/lvaf101","journal-title":"Eur J Endocrinol"},{"key":"1740_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"FF Casanueva","year":"2006","unstructured":"Casanueva FF, Molitch ME, Schlechte JA et al (2006) Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65:265\u2013273. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02562.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1740_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12020-022-03145-1","volume":"78","author":"R Krysiak","year":"2022","unstructured":"Krysiak R, Kowalcze K, Okopie\u0144 B (2022) Cardiometabolic profile of young women with hypoprolactinemia. Endocrine 78:135\u2013141. https:\/\/doi.org\/10.1007\/s12020-022-03145-1","journal-title":"Endocrine"},{"key":"1740_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/biom14101335","volume":"14","author":"R Krysiak","year":"2024","unstructured":"Krysiak R, Kowalcze K, Szkr\u00f3bka W, Okopie\u0144 B (2024) Increased cardiometabolic risk in men with hypoprolactinemia: a pilot study. Biomolecules 14:1335. https:\/\/doi.org\/10.3390\/biom14101335","journal-title":"Biomolecules"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01740-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01740-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01740-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:15:28Z","timestamp":1787044528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01740-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1740"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01740-3","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"11 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"139"}}